A retro-reflector is a device or surface that is capable of reflecting light back to its source with minimal scattering. UA’s Russell Chipman, Ph.D., and Karlton Crabtree, Ph.D., created a novel design for a retro-reflector that increases the reflection efficiency while reducing the complexity of the system.
The most common method of managing pain is the use of opioids like morphine, oxycodone, and fentanyl, all of which are highly addictive. Research has shown that therapeutic exposure to low-intensity green light can reverse chronic pain.
Cryptosporidium is a protozoan parasite that lives in the intestine and is a major cause of moderate-to-severe diarrhea in humans and livestock worldwide. Michael Riggs, DVM, PhD, DACVP, has developed monoclonal antibodies capable of detecting Cryptosporidium antigens.
For the OSIRIS-REx asteroid sample return mission that the University of Arizona is leading, researchers developed the OSIRIS-REx Camera Suite (OCAMS). One of the cameras, PolyCam, has a novel roller screw designed to meet the accuracy, reliability, and power requirements that the mission demands.
Ovarian cancer accounts for about three percent of cancers among women, but results in the most deaths. Raymond K. Kostuk Ph.D. and Jennifer Barton Ph.D. have dedicated their recent research to an imaging method and device for detection and diagnosis of ovarian cancer.
Most sunscreens are made with potentially harmful chemicals. Professor Douglas Loy, Ph.D., and graduate assistant Robb Bagge have developed new bio-based particles for sun-blocking purposes. The resulting sunscreens provide an inexpensive, non-toxic alternative that absorbs UV radiation.
Christopher Walker, Ph.D., a professor of astronomy at the University of Arizona’s Steward Observatory, has developed a new transistor design that could be used for safer high-resolution medical imaging as well as security and radar imaging, spectroscopy and ultra-fast data links.
Parkinson’s disease often requires long-term use of levodopa, a therapy that can induce dyskinesia. To both treat and prevent levodopa-induced dyskinesia, two UA researchers have repurposed ketamine to improve Parkinson’s patients’ health and wellbeing.